Sat, Feb 28, 2015, 11:53 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

OncoGenex Pharmaceuticals, Inc. Message Board

  • mr_ssssamsa mr_ssssamsa Sep 2, 2012 11:30 PM Flag

    Medivation drug approved

    Approval was expected but it came 3 months ahead of the PDUFA date.

    Given the apparent synergies, at least preclinically, with 0GX-011 for which OGXI presented evidence at ASCO 2011, it's conceivable that Teva would now fund a combination trial. I think it's more likely that they'll wait until MDVN shows efficacy in the larger pre-chemo setting. By then they may have results from SYNERGY, and that will probably be the main factor determining whether they want to initiate additional new trials of 011.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.30+0.01(+0.22%)Feb 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.